Alliance Foundation Trials, LLC (AFT) and Pfizer Inc. today announced results from the phase III PATINA trial demonstrating that the addition of palbociclib (IBRANCE) to current standard-of-care first ...
Rx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will launch purpleDx, a cardiopulmonary assessment app built to medical ...
STOCKHOLM, Dec. 6, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that discrete proton arc optimization in RayStation, combined with standard delivery techniques and ...